Literature DB >> 17135284

Reduction in infarct size, but no functional improvement after bone marrow cell administration in a porcine model of reperfused myocardial infarction.

Amber D Moelker1, Timo Baks, E J van den Bos, R J van Geuns, P J de Feyter, Dirk J Duncker, W J van der Giessen.   

Abstract

AIMS: Stem cell therapy after myocardial infarction (MI) has been studied in models of permanent coronary occlusion. We studied the effect of intracoronary administration of unselected bone marrow (BM) and mononuclear cells (MNC) in a porcine model of reperfused MI. METHODS AND
RESULTS: In 34 swine, the left circumflex coronary artery was balloon-occluded for 2 h followed by reperfusion. Ten swine without MI served as controls. All swine underwent magnetic resonance imaging (MRI) 1 week post-MI. The next day, 10 of the 30 surviving MI swine received BM, 10 other MI swine received MNC, and the remaining MI swine received medium intracoronary. Four weeks later, all swine underwent a follow-up MRI. One week after MI, end-diastolic volume (92+/-16 mL) and left ventricular (LV) weight (78+/-12 g) were greater, whereas ejection fraction (40+/-8%) was lower than in controls (69+/-11 mL, 62+/-13 g, and 53+/-6%). Injection of BM or MNC had no effect on the MI-induced changes in global or regional LV-function. However, there was a significant reduction in infarct size 4 weeks after MNC injection (-6+/-3%) compared with the medium (-3+/-5%).
CONCLUSION: Intracoronary injection of BM or MNC in swine does not improve regional or global LV-function 4 weeks after injection. However, a reduction in infarct-size was noted after MNC injection.

Entities:  

Mesh:

Year:  2006        PMID: 17135284     DOI: 10.1093/eurheartj/ehl401

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  21 in total

Review 1.  Stem cell therapy: MRI guidance and monitoring.

Authors:  Dara L Kraitchman; Wesley D Gilson; Christine H Lorenz
Journal:  J Magn Reson Imaging       Date:  2008-02       Impact factor: 4.813

2.  Cell transplantation for cardiac regeneration: where do we stand?

Authors:  E J van den Bos; W J van der Giessen; D J Duncker
Journal:  Neth Heart J       Date:  2008       Impact factor: 2.380

Review 3.  Cell-based therapies for cardiac disease: a cellular therapist's perspective.

Authors:  Pampee P Young; Richard Schäfer
Journal:  Transfusion       Date:  2014-08-22       Impact factor: 3.157

4.  FoxO4 promotes early inflammatory response upon myocardial infarction via endothelial Arg1.

Authors:  Min Zhu; Sean C Goetsch; Zhaoning Wang; Robert Luo; Joseph A Hill; Jay Schneider; Sidney M Morris; Zhi-Ping Liu
Journal:  Circ Res       Date:  2015-10-05       Impact factor: 17.367

5.  PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice.

Authors:  Rui Wang; Lei Xi; Rakesh C Kukreja
Journal:  J Pharmacol Exp Ther       Date:  2017-01-25       Impact factor: 4.030

6.  Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials.

Authors:  Virginie F Forest; Ashok M Tirouvanziam; Christian Perigaud; Sarah Fernandes; Marion S Fusellier; Jean-Claude Desfontis; Claire S Toquet; Marie-Françoise M Heymann; Dominique P Crochet; Patricia F Lemarchand
Journal:  Stem Cell Res Ther       Date:  2010-03-15       Impact factor: 6.832

Review 7.  Cell-based therapy for heart disease: a clinically oriented perspective.

Authors:  Philippe Menasche
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

Review 8.  Noninvasive cardiovascular imaging techniques for basic science research: application to cellular therapeutics.

Authors:  Wesley D Gilson; Dara L Kraitchman
Journal:  Rev Esp Cardiol       Date:  2009-08       Impact factor: 4.753

9.  Dysregulation of matrix metalloproteinases and their tissue inhibitors is related to abnormality of left ventricular geometry and function in streptozotocin-induced diabetic minipigs.

Authors:  Lin Lu; Qi Zhang; Li Jin Pu; Wen Hui Peng; Xiao Xiang Yan; Lin Jie Wang; Qiu Jing Chen; Zheng Bing Zhu; Jean-Baptiste Michel; Wei Feng Shen
Journal:  Int J Exp Pathol       Date:  2008-04       Impact factor: 1.925

10.  Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulating factor-mobilized apheresis product may not improve remodelling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarction.

Authors:  Ranil de Silva; Amish N Raval; Mohiuddin Hadi; Karena M Gildea; Aylin C Bonifacino; Zu-Xi Yu; Yu Ying Yau; Susan F Leitman; Stephen L Bacharach; Robert E Donahue; Elizabeth J Read; Robert J Lederman
Journal:  Eur Heart J       Date:  2008-05-23       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.